We have recently demonstrated the diagnostic value of a new immunophenotype of blood endothelial progenitor cells (EPCs ¼ CD45neg/CD34pos/CD144pos) and endothelial microparticles (EMPs ¼ CD45neg/CD144pos/AnnexinVpos) in patients with arterial erectile dysfunction (ED) according to severity of cavernous arterial insufficiency evaluated through penile Doppler. The aim of this study was to evaluate both EPCs and EMPs in patients with arterial ED and metabolic syndrome (MetS), comparing these patients with another group of patients without MetS and ED and a third group with MetS but without ED. For this study 50 patients with arterial ED and MetS were selected (age: 55.0±3.0 years; range: 47--60). A group of age-matched (age: 54.0 ± 2.0 years; range: 44--60) patients without arterial ED and MetS (n ¼ 30), and another group of age-matched (age: 57.0 ± 4.0 years; range: 40--62) patients with MetS but without ED (n ¼ 20) represented the control groups. EPCs and EMPs were significantly higher in patients compared with other groups (Po0.01). Both EPCs and EMPs correlated positively with the age, body mass index, and score of international index of ED (version five items) and with the following cavernous artery indices: peak systolic velocity, acceleration time and intima-media thickness. Among control groups patients with MetS but without ED showed serum concentrations of EPCs and EMPs significantly higher (Po0.05) compared with patients without MetS and ED. Patients with arterial ED and MetS have higher EPCs and EMPs compared with patients with MetS but without ED and patients without MetS and ED.
INTRODUCTION
We have recently demonstrated the diagnostic value of a new immunophenotype of blood endothelial progenitor cells (EPCs ¼ CD45neg/CD34pos/CD144pos) and endothelial microparticles (EMPs ¼ CD45neg/CD144pos/AnnexinVpos) in patients with arterial erectile dysfunction (ED) according to severity of cavernous arterial insufficiency evaluated through penile Doppler, showing that serum concentrations of these immunophenotypes are significantly higher compared with patients with psychogenic ED and among patients with arterial ED, those with severe arterial insufficiency showed significantly higher serum concentrations of EPCs and EMPs. 1 On this basis, the present study was undertaken to evaluate the number of EPCs and EMPs in patients with metabolic syndrome (MetS) and ED of arterial origin, which is a very common category among patients with sexual dysfunction in clinical practice. This clinical model seemed to us suitable to gain more insight into the balance between bone marrow endothelial repair mechanism and endothelial dysfunction in the manifestation of the clinical symptoms. To accomplish this, 50 patients with arterial dysfunctional-based ED and MetS, established by the Adult Treatment Panel (ATP) III criteria (NCEP ATPIII, 2002), were selected and the number of circulating EPCs and EMPs was determined. Two different groups of patients were enrolled as control: (a) patients without arterial ED and MetS; and (b) patients with MetS but without ED.
PATIENTS AND METHODS

Patient selection
In our Andrological Institute all patients with sexual dysfunction and/or cardiovascular risk factors are routinely subjected to extensive evaluation of endothelial dysfunction, which includes dynamic penile Doppler and evaluation of serum concentrations of EPCs and EMPs; then we perform a monthly retrospective analysis of data obtained.
For this study 50 patients with arterial ED and MetS were selected (age: 55.0 ± 3.0 years; range: 47--60). The diagnosis of arterial ED was made when all the following criteria were fulfilled: (a) international index of erectile function (IIEF-5) score o21; 2 (b) cavernousal artery peak systolic velocity (PSV) o30 cm s À1 , 10 and 20 min after the intracavernousal injection of alprostadil (20 mg) by echo color Doppler; 3 and (c) acceleration time 4110 ms. 4 The diagnosis of MetS was made according to the ATP III criteria. 5 Patients were excluded if they (a) had severe hypogonadism (serum total testosterone levels o8 nmol l À1 (o231 ng dl À1 ) 6 and (b) smoked cigarettes. They underwent blood withdrawal (10 ml), for EPC and EMP measurements by flow cytometry.
Characteristics and selection of controls
Two control groups were selected retrospectively for this study from the internal database. EMP detection. ECD anti-human CD45 (IL), phycoerythrin-conjugated anti-human CD144 (IL) and fluorescein isothiocyanate-conjugated annexin V (IL) were used for EMP flow detection by flow cytometry. Particles with o1.5 mm. Sizes were gated on forward vs side scatter histogram. To exclude microparticles originating from leukocyte, we considered only events within the CD45 neg gate. CD144 pos events expressing phosphatidylserine in the outer membrane leaflet following annexin V staining were defined EMPs. They were reported as percentage of total events.
Appropriate isotype controls were used for each staining procedure as negative controls to set the appropriate regions. Flow cytometric analysis was conducted for 600 s or 100 000 events whichever occurred first. The same operator, blinded with respect to the sample origin (control or patient), performed all the tests throughout the study. 
Statistical analysis
Results are shown as median and percentiles. The data were analyzed by 1-way analysis of variance followed by the Duncan's multiple range test. Correlation analysis was carried out by Pearson's test. Statistical analysis was conducted using SPSS 10.0 for windows (NY, USA; SPCC). A P value o0.05 was accepted as statistically significant.
RESULTS
The 50 ED patients with MetS enrolled in this study had an average IIEF-5 score of 10±2.0 (range: 5--19). Among these patients 50/50 (100%) of them showed a waist circumference 4102 cm, other 40/50 patients (80%) showed a serum levels of high-density lipoprotein cholesterol o40 mg dl
À1
, 39/50 patients (78%) showed fasting glucose levels 4110 mg dl
, 35/50 patients (70%) showed serum levels of triglycerides 4150 mg dl À1 , finally 37/50 patients (74%) were affected by hypertension. In particular 20 patients (40%) showed a simultaneous presence of three criteria of MetS, other 15 patients (30%) showed four signs of this syndrome and finally, other 15 patients (30%) showed all criteria of MetS.
Patients with ED and MetS showed a serum concentration of EPCs significantly higher compared with control groups (Po0.01) (Figure 2 , upper panel) and serum concentration of EPCs correlated positively with age, body mass index, PSV, acceleration time, cavernous artery intima-media thickness and IEEF-5 score (Table 1) .
Among control groups, patients with MetS but without ED showed a serum concentration of EPCs, significantly higher compared with patients without MetS and ED (Po0.05).
Patients with ED and MetS showed a serum concentration of EMPs significantly higher (Po0.01) compared with control groups (Figure 2 , lower panel) and serum concentration of EMPs correlated positively with age, body mass index, PSV, acceleration time, intima-media thickness and IIEF-5 score (Table 1) .
Among control groups, patients with MetS, but without ED, showed a serum concentration of EMPs, significantly higher compared with patients without MetS and ED (Po0.05). Finally, a direct significant correlation was found between EPCs and EMPs (r ¼ 0.60; Po0.01).
DISCUSSION
This study evaluated the number of circulating EPCs and EMPs, respectively, markers of endothelial reparative response 7--12 and endothelial damage 13 in patients with arterial dysfunctional-based ED and MetS, 14 because few data are available in these patients, whereas studies have been conducted in ED patients with diabetes mellitus 15 or obesity. 16 In addition, these studies have assessed only one of these markers of endothelial dysfunction, whereas enough evidences have now accumulated to suggest that the simultaneous measurement of both EPCs and EMPs would be more useful to evaluate their role as biomarkers of cardiovascular diseases and atherosclerotic complication or progression.
We found that patients with arterial ED and MetS had higher circulating EPCs and EMPs compared with healthy men, adding further evidence that these parameters are markers of endothelial dysfunction. This higher endothelial repair commitment suggests a severe vascular abnormality in these patients. EMPs are released as consequence of endothelial dysfunction, atherogenesis and endothelial apoptotic processes. The significant positive correlation between EPCs and EMPs at baseline suggests a more severe vascular damage in these men. The increase of these more endothelial regenerating EPCs may be able to rebuild the endothelial monolayer of the corpus cavernosum with amelioration of erectile function and protection from the disease progression in these patients.
The first EPC phenotype was defined by the presence of the following antigens in blood cells: CD34, CD133 (Prominin 1) and vascular endothelial growth factor receptor 2 (or kinase insert domain receptor (KDR)). 8 Many articles have reported statistically significant correlation between the number of this EPC subset in the blood with the presence of adverse cardiovascular outcomes. However, few studies have attempted to formally compare the functional properties of this EPC subset in hematopoietic and endothelial clonogenic assays to gain more insight in the biology of the phenotype used, namely to assess the identity of their clonal progeny, which participates in vessel repair. 17, 18 No clear evidence has been reported about the existence of specific markers, which allows to prospectively isolate EPCs with a phenotype superior to the one so far described. 18 In patients with ED, the number of EPCs with the phenotype CD34 pos /CD133 pos /KDR pos is reduced and this reduction seems to be greater in presence of cardiovascular risk factors (cigarette smoke, hypertension, diabetes mellitus, obesity and dyslipidemia). 14, 16, 19 In addition the reduced number of CD34 pos /CD133 pos / KDR pos EPCs is an independent risk factor for ED in patients with known coronary artery disease. Moreover, Werner et al., 20 in a large study (519 patients examined) on association between EPCs and cardiovascular outcomes, examining a selected category with coronary artery disease (confirmed with angiography) and evaluating after 12 months the association between baseline levels of EPCs and death from cardiovascular causes, the occurrence of a first major cardiovascular event (myocardial infarction, hospitalization, revascularization or death from cardiovascular causes), revascularization, hospitalization and death from all causes, showed (after adjustment for age, sex, vascular risk factors and other relevant variables) that increased levels of EPCs were associated with a reduced risk of death from cardiovascular causes, a first major cardiovascular event, revascularization and hospitalization. Therefore, these findings suggest that EPCs may represent a link between cardiovascular risk factors, endothelial dysfunction and ED. 15 The apparent discrepancy between these studies and the present one may relate to the different phenotype of EPCs evaluated. In fact, also the study of Werner, 20 examined a early phase of reparative response represented with the classic phenotype CD34 pos /CD133 pos /KDR pos and the model does not include the evaluation of two functional markers of endothelial damage, on the contrary that in our study, where an cellular sign of endothelial injury (EMPs) correlates with a marker of endothelial reparative response (EPCs); in addition data on EPCs culture showing that Anti CD144 (vascular endothelial cadherin) is almost absent between 5 and 8 culture days, whilst, together to Anti CD34 and Anti CD31 is over represented between 30 and 32 culture days, 21 showing that the phenotype CD45neg/CD34pos/ CD144pos used in the present study represented a late group of differentiation in reparative response mediated by EPCs.
Moreover, more recently, an increased number of a particular phenotype of EPCs, those positive for osteocalcin, a marker of circulating osteogenic cells, has also been reported in patients with ED 22 and a recent clinical evaluation of patients with severe peripheral arterial disease shown that number of EPCs (CD144pos) was significantly increased with respect to healthy subjects but the concomitant CD34 þ cell count was significantly decreased. 21 It is now clear that there are distinct EPC sub-populations with different phenotype and biological properties. 6 Cells progress from stem cell stage to the final mature cell of each single lineage, through successive progenitor cell stages, 23 and because uniform criteria to identify these cells are lacking, we followed the proposal outlined by Case et al. 17 They suggested to use the CD45 neg / CD34 pos phenotype, because these cells form colonies of mature endothelial cells in a clonogenic in-vitro assay of endothelial cells. Therefore, probably these cells behave to a greater extent as true endothelial progenitors 19 and accordingly, CD45 neg /CD34 pos / CD144 pos cells form endothelial cells in culture. 21 In addition to EPCs, microparticles of endothelial origin (EMPs) may be found in the general circulation. EMPs are membrane fragments which increase in several pathological conditions, including atherosclerosis, sepsis, diabetes mellitus and during process of apoptosis. 24 The main characteristics of these elements are the small dimension (o1.5 mm) and the externalization of phosphatidylserine revealed by annexin V binding. 25 EMPs are regarded as markers of cardiovascular dysfunction with a pro-thrombotic role associated with risk factors, such as those which characterize the MetS. 26--30 The percentage of EMPs is higher in patients with ED and inversely correlated with the IIEF-5 score. 31 The presence of diabetes mellitus seems to be associated with a greater elevation of EMPs. 19 Many studies have evaluated the correlation between EPCs or EMPs with the severity of cardiovascular disease. Only few have assessed simultaneously both biomarkers and correlated them with the arterial condition.
EMPs, defined by another phenotype, CD31 pos /CD42 neg and CD31 pos /CD42 pos , have been reported elevated in patients with ED and diabetes mellitus and independently involved in the pathogenesis of ED. 31 The data of the literature shown that EMPs inversely correlate with the IIEF score in both diabetic and nondiabetic patients and multivariate analysis in the study of Boulanger, corrected for confounding factors, demonstrate that EMPs are the only independent predictor of the IIEF score. 30 In addition, ED patients with or without diabetes mellitus have significantly higher EMPs (CD62 pos ) than non-diabetic men without ED. The EMPs (CD62 pos )/EMPs (CD31 pos ) ratio, an index of endothelial activation (high ratio) or apoptosis (low ratio), is lowest in ED diabetic patients, therefore, these findings suggest that the EMP increase in ED diabetic patients is consistent with an increased apoptotic activity. 31 In conclusion, the results of our study conducted in patients with ED and MetS imply the same conclusion, in fact these patients share with atherosclerotic patients a common picture of endothelial damage and markers of this dysfunction. This is sustained by the significant correlation between EPCs or EMPs, both bio-markers of endothelial dysfunction, with indices of cavernous artery dysfunction (PSV, acceleration time and intimamedia thickness), finally, the patients with arterial ED and MetS have higher blood concentrations of EPCs and EMPs compared with healthy men.
